Collaboration drives innovation. At Pacira, we build partnerships rooted in a shared mission to advance non-opioid pain management—uniting purpose, urgency and results to deliver transformative care for patients.
Pacira seeks to transform the lives of patients by delivering innovative, non-opioid pain therapies to the market. Our business development team evaluates opportunities in the musculoskeletal and pain adjacencies across two broad categories.
We’re interested in innovative assets that focus on non-opioid or opioid-sparing pain management, including products that complement our current portfolio or could gain value from our field expertise, existing partnerships and commercial infrastructure.
We’re open to the opportunity for collaboration or co-marketing as well as asset acquisition or license.
We also seek innovative, non-opioid, development-stage assets, with preference for later-stage assets with clinical data and proof of mechanism.
We’re open to asset acquisition as well as collaboration based on co-development and other shared activities and investments.
We invite companies and researchers who share our purpose and sense of urgency to contact our Business Development team at [email protected] to discuss partnership opportunities.
At Pacira, we follow a rigorous process to select vendors who align with our mission and share our commitment to innovation, sustainability and operational excellence. For more information, review our Supplier Code of Conduct and other sustainability policies.
To inquire about our procurement and supply chain efforts, please complete the form below.
Through grants and charitable giving, we support research, education and medical missions that bring meaningful change to communities worldwide.
For any questions or inquiries about grants and funding opportunities, please contact us at [email protected].